Try our beta test site

GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy

This study has been completed.
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Sandoz
ClinicalTrials.gov Identifier:
NCT01274182
First received: January 10, 2011
Last updated: December 16, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: December 14, 2016